Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...

Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal ...

A new covid-19 variant called XEC may spread more easily than past variants, but current vaccines are still effective against ...

Another Covid-19 wave is likely this summer, a modeller says, as a new mutant coronavirus variant emerges overseas. Experts ...

Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...

Omicron variant KP.3.1.1, also known as deFLuQE, made up over half (52.7%) of COVID-19 cases between Sept. 1 and Sept. 14. However, XEC and a variant known as MV.1 seem poised to become the next ...

For those wanting the home test kit, free rapid antigen tests will continue to be available through local public health units ...

Researchers indicate that the vaccine and booster shots should protect against the new variant. Here is what we know about ...

The CDC has not confirmed whether there are any unique symptoms from the XEC variant. USA TODAY has reached out to CDC ...

Covid-19 vaccines are available across the United States. Vaccines represent the best protection against sever illness and ...

XEC is also an offshoot of omicron, the widely spread variant that formed in 2021. According to experts, it has some of omicron’s features, too — like less severe symptoms and easy transmissibility.

XEC is the latest COVID-19 variant spreading in Europe and the U.S. Infectious disease doctors explain XEC symptoms, ...